Investigating the Association between COVID-۱۹ Prognosis and Demographic and Clinical Features, Underlying Diseases, and Drug and Supplement Use in Patients Hospitalized in Zabol, Iran: A Single-Center Retrospective Study

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 160

This Paper With 12 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IEM-9-2_008

تاریخ نمایه سازی: 29 مهر 1402

Abstract:

Backgrounds: The primary goal of this study was to identify the potential association between COVID-۱۹ prognosis and demographic and clinical features, underlying diseases, and drug and supplement use in patients admitted to Amir al-Momenin hospital in Zabol. Materials & Methods: This retrospective study surveyed the electronic health records of ۸۴۸ COVID-۱۹ patients hospitalized in a tertiary referral hospital in southeastern Iran from the beginning of the COVID-۱۹ outbreak until the end of February ۲۰۲۱. Univariate and multiple analytical tests including unconditional and penalized logistic regressions were used for statistical analysis. Findings: Out of a total of ۸۴۸ patients, ۳۷۱ (۴۳.۷۵%) patients were female, and ۴۷۷ (۵۶.۲۵%) patients were male. Age, underlying pulmonary and cardiovascular diseases, and loss of consciousness predicted a higher mortality rate. On the contrary, a negative chest X-ray was associated with a lower risk of death. Conclusion: Identifying predisposing factors of mortality in COVID-۱۹ patients will help physicians provide more intensive care to those at higher risk of death by classifying patients based on risk factors and underlying diseases.

Authors

Shaghayegh Hemat jouy

Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, Central Tehran Branch, Islamic Azad University, Tehran, Iran

farzan Lotfi

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran

Rahim Akrami

Department of Epidemiology & Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

jafar shahraki

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran

Roghayeh Sheervalilou

Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran

Omolbanin Shahraki

Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran

Habib Ghaznavi

Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Wu F, Zhao S, Yu B, Chen YM, Wang W, ...
  • Zhou P, Yang XL, Wang XG, Hu B, Zhang L, ...
  • Gorbalenya AE, Baker SC, Baric R, Groot RJ, Drosten C, ...
  • Cunningham AC, Goh HP, Koh D. Treatment of COVID-۱۹: Old ...
  • Lu H. Drug treatment options for the ۲۰۱۹-new coronavirus (۲۰۱۹-nCoV). ...
  • Ghaznavi H, Mohammadghasemipour Z, Shirvaliloo M, Momeni MK, Metanat M, ...
  • Sheervalilou R, Shirvaliloo M, Dadashzadeh N, Shirvalilou S, Shahraki O, ...
  • Sheervalilou R, Shirvaliloo M, Sargazi S, Bahari S, Saravani R, ...
  • Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, ...
  • Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has ...
  • Wang M, Cao R, Zhang L, Yang X, Liu J, ...
  • Raoult D, Hsueh PR, Stefani S, Rolain JM. COVID-۱۹ therapeutic ...
  • Shiraki K, Daikoku T. Favipiravir, an anti-influenza drug against life-threatening ...
  • Amsden G. Anti-inflammatory effects of macrolides—an underappreciated benefit in the ...
  • Gautret P, Lagier JC, Parola P, Meddeb L, Mailhe M, ...
  • Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. ...
  • World Health Organization. Coronavirus disease ۲۰۱۹ (COVID-۱۹): Situation report, ۷۳. ...
  • Wu Z, McGoogan JM. Characteristics of and important lessons from ...
  • Jalili M, Payandemehr P, Saghaei A, Sari HN, Safikhani H, ...
  • Arman A, Tajik M, Nazemipour M, Ahmadinejad Z, Shahrestanaki SK, ...
  • Nikpouraghdam M, Farahani AJ, Alishiri G, Heydari S, Ebrahimnia M, ...
  • Zali A, Gholamzadeh S, Mohammadi G, Looha MA, Akrami F, ...
  • Li X, Xu S, Yu M, Wang K, Tao Y, ...
  • Brusselaers N, Steadson D, Bjorklund K, Breland S, Stilhoff Sörensen ...
  • Zheng F, Tang W, Li H, Huang Y, Xie Y, ...
  • Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, ...
  • Chen J, Qi T, Liu L, Ling Y, Qian Z, ...
  • Du Y, Tu L, Zhu P, Mu M, Wang R, ...
  • Drosten C, Günther S, Preiser W, van der Werf S, ...
  • Garg S, Kim L, Whitaker M, O’Halloran A, Cummings C, ...
  • Dadras O, SeyedAlinaghi S, Karimi A, Shamsabadi A, Qaderi K, ...
  • Garbern SC, Pryanka R, O’Reilly GM, Bills CB, Schultz M, ...
  • Horby P, Lim WS, Emberson J, Mafham M, Bell J, ...
  • Wu J, Liu J, Zhao X, Liu C, Wang W, ...
  • Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, ...
  • Wang D, Hu B, Hu C, Zhu F, Liu X, ...
  • نمایش کامل مراجع